azelaic acid
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0591-2131 -
Package NDC
0591-2131-55 -
Application number
ANDA208011 -
SPL ID
38d8c966-bb27-4b39-b436-4e7ffbd2d134 -
SPL set ID
66298d50-d4e2-4852-bbab-581389c488cb -
UNII
F2VW3D43YT -
RxCUI
1041518
What the source publishes
- Labeler
- Actavis Pharma, Inc.
- Active ingredients
- azelaic acid
- Form
- GEL
- Routes
- TOPICAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "azelaic acid",
"splId": "38d8c966-bb27-4b39-b436-4e7ffbd2d134",
"labels": [
{
"setId": "66298d50-d4e2-4852-bbab-581389c488cb",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=66298d50-d4e2-4852-bbab-581389c488cb",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=66298d50-d4e2-4852-bbab-581389c488cb"
}
],
"routes": [
"TOPICAL"
],
"labeler": "Actavis Pharma, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 TUBE in 1 CARTON (0591-2131-55) / 50 g in 1 TUBE",
"package_ndc": "0591-2131-55",
"identifierStatus": "well-formed",
"marketing_start_date": "20181119"
}
],
"productId": "0591-2131_38d8c966-bb27-4b39-b436-4e7ffbd2d134",
"useDomain": "unknown",
"dosageForm": "GEL",
"productNdc": "0591-2131",
"deaSchedule": null,
"genericName": "azelaic acid",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "AZELAIC ACID",
"strength": ".15 g/g"
}
],
"applicationNumber": "ANDA208011",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20181119",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000008841",
"N0000009982"
],
"unii": [
"F2VW3D43YT"
],
"rxcui": [
"1041518"
],
"spl_set_id": [
"66298d50-d4e2-4852-bbab-581389c488cb"
],
"pharm_class_pe": [
"Decreased Protein Synthesis [PE]",
"Decreased Sebaceous Gland Activity [PE]"
],
"manufacturer_name": [
"Actavis Pharma, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0591-2131_38d8c966-bb27-4b39-b436-4e7ffbd2d134"